Literature on Xerostomia and Cancer Therapies
 
A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy (abstract)
Strigari et al.
2010, International Journal of Radiation Oncology * Biology * Physics
The purpose of this study was to investigate the predictors of incidence and duration of xerostomia (XT) based on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole organ (TG) in head-and-neck cancer patients treated with intensity-modulated radiotherapy.
 
Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: A single-center, single blind clinical trial
Chitapanarux et al.
2008, Journal of the Medical Association of Thailand
The purpose of this study was to determine the efficacy and safety of oral pilocarpine tablet in symptomatic relief of post-radiation xerostomia in head and neck cancer patients.
 
Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life
Van Rij et al.
2008, Radiation Oncology
Study assessed the impact of intensity modulated radiotherapy versus conventional radiation on late xerostomia and Quality of Life aspects in head and neck cancer patients.
 
Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients (abstract)
De Castro et al.
2006, Current Opinion in Oncology
The review focuses on evaluation, prevention and management of radiation therapy-induced xerostomia.
 
Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head and neck cancer (abstract)
Meirovitz et al.
2006, International Journal of Radiation Oncology * Biology * Physics
The purpose of this study was to assess observer-based vs. patient self-reported scoring of xerostomia after intensity-modulated radiotherapy (IMRT) of head and neck cancer.
 
Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer
Taweechaisupapong et al.
2006, Australian Dental Journal
The aim of this study was to quantify improvement in clinical symptoms and salivary function after treatment of post-radiation xerostomia with pilocarpine lozenges.
 
Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head and neck cancer: Initial report
Jabbari et al.
2005, International Journal of Radiation Oncology * Biology * Physics
Study compared quality of life (QoL) and xerostomia between head and neck cancer patients who received standard radiotherapy and patients matched by factors known to affect QoL who received intensity-modulated radiotherapy.
Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy (abstract)
Henson et al.
2001, Oral Oncology
The article’s findings suggest that despite parotid-sparing radiotherapy, salivary flow rates from treated and spared glands and xerostomia related quality of life decrease at the completion of radiotherapy.